Post-lanosterol biosynthesis of cholesterol and cancer. 2012

Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
Servicio de Bioquímica-Investigación, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. miguel.a.lasuncion@hrc.es

Mammalian cells require cholesterol for proliferation. Cholesterol contributes not only to the physicochemical properties of membranes but also to the organization of lipid rafts involved in signal transduction. Inhibition of cholesterol biosynthesis from lanosterol results in the inhibition of cell cycle progression and, in certain cell types, also in the induction of cell differentiation. Cholesterol metabolism, thus, appears to play a relevant role in the decision making between cell proliferation and differentiation. Several regulators of cholesterol metabolism, including certain microRNAs, are also involved in cell cycle regulation. The relevance of these processes in cancer underscores the interest for studying the role of cholesterol in tumorigenesis and exploring the possibility of interfering with the growth of malignant cells by manipulation of cholesterol metabolism.

UI MeSH Term Description Entries
D007810 Lanosterol A triterpene that derives from the chair-boat-chair-boat folding of 2,3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS. Kryptosterol,4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D021962 Membrane Microdomains Detergent-insoluble CELL MEMBRANE components. They are enriched in SPHINGOLIPIDS and CHOLESTEROL and clustered with glycosyl-phosphatidylinositol (GPI)-anchored proteins. Lipid Rafts, Cell Membrane,Sphingolipid Microdomains,Sphingolipid-Cholesterol Rafts,Membrane Microdomain,Microdomain, Membrane,Microdomain, Sphingolipid,Microdomains, Membrane,Microdomains, Sphingolipid,Sphingolipid Cholesterol Rafts,Sphingolipid Microdomain,Sphingolipid-Cholesterol Raft

Related Publications

Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
September 1981, Chemical & pharmaceutical bulletin,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
May 1983, Chemical & pharmaceutical bulletin,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
May 1983, Chemical & pharmaceutical bulletin,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
January 1999, Critical reviews in biochemistry and molecular biology,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
May 1984, Chemical & pharmaceutical bulletin,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
June 1966, Biochemistry,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
March 1982, Lipids,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
January 2008, Bioorganic & medicinal chemistry,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
January 1986, Journal of lipid research,
Miguel A Lasunción, and Covadonga Martín-Sánchez, and Alberto Canfrán-Duque, and Rebeca Busto
April 1998, Molecules and cells,
Copied contents to your clipboard!